中国临床解剖学杂志 ›› 2018, Vol. 36 ›› Issue (5): 532-535.doi: 10.13418/j.issn.1001-165x.2018.05.010

• 实验研究 • 上一篇    下一篇

还原型谷胱甘肽对活性氧介导的系统性红斑狼疮患者中性粒细胞NETosis的影响

廖攀1,2, 何懿1,2, 杨方圆1,2, 庄坚1,2, 罗贵湖1,2, 翟泽清1,2, 孙尔维1,2   

  1. 1.南方医科大学第三附属医院风湿免疫科,  广州   510630; 2.广东省骨科研究院临床免疫研究所,  广州   510630
  • 收稿日期:2018-07-31 出版日期:2018-09-25 发布日期:2018-10-26
  • 通讯作者: 孙尔维,教授,博士生导师,E-mail:sunew@smu.edu.cn
  • 作者简介:廖攀(1989-),硕士,研究方向:固有免疫与自身免疫性疾病,E-mail:277460258@qq.com
  • 基金资助:

    国家自然科学基金(81501417,  81671623)

The effect of reduced glutathione on the ROS-mediated NETosis by neutrophils from patients with systemic lupus erythematosus

LIAO Pan 1,2,HE Yi 1,2,YANG Fang-yuan 1,2,ZHUANG Jian 1,2,LUO Gui-hu 1,2,ZHAI Ze-qing 1,2,SUN Er-wei 1,2   

  1. 1. Department of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical University, Guangzhou 510630, China; 2. Institute of Clinical Immunology, Academy of Orthopedics, Guangdong Province, Guangzhou 510630, China
  • Received:2018-07-31 Online:2018-09-25 Published:2018-10-26

摘要:

目的 探讨抗氧化剂还原型谷胱甘肽(GSH)能否通过调控中性粒细胞ROS水平从而抑制中性粒细胞发生NETosis,减少中性粒细胞胞外诱捕网(neutrophil extracellular traps, NETs)的形成,为临床开发新的治疗系统性红斑狼疮(SLE)的药物提供理论基础。  方法 采用梯度离心法分离SLE患者外周血中性粒细胞,利用佛波酯(PMA)诱导中性粒细胞发生NETosis后,检测各组中性粒细胞胞内ROS水平并观察其NETs产生情况。  结果 与PMA处理组比较,经过GSH预处理的SLE患者中性粒细胞体外诱导NETs产生明显减少。同时,GSH也能明显降低SLE患者中性粒细胞胞内ROS水平。  结论 GSH可能通过调控SLE患者中性粒细胞ROS的水平,从而抑制其发生NETosis,提示GSH可能在SLE治疗中发挥作用。

关键词: 还原型谷胱甘肽,  系统性红斑狼疮,  中性粒细胞,  NETosis,  活性氧

Abstract:

Objective Evidence has demonstrated that the formation of neutrophil extracellular traps (NETs) formation mediated by neutrophil plays an important role in the pathogenesis and progression of systemic lupus erythematosus (SLE). In this study, we aimed to investigate whether reduced glutathione (GSH) could decrease the level of intracellular reactive oxygen species (ROS) or inhibit NETs formation.  Methods Neutrophils were isolated from peripheral blood of SLE patients by gradient centrifugation method dextran sedimentation and centrifugation, and then were stimulated with phorbol 12-myristate 13-acetate (PMA). The production of intracellular ROS and the formation of NETs were examined.   Results   Compared with the PMA group treated with PMA, the group preprocessing with GSH could markedly suppress formation of NET by neutrophils from SLE patients. Moreover, the production of intracellular ROS production was significantly decreased in GSH-treated neutrophils from SLE patients. Conclusion GSH can significantly inhibit the process of neutrophils' NETosis from SLE patients through modulating the intracellular ROS production. These results indicates that GSH might be a potential therapeutic agent for SLE.

Key words: Reduced glutathione,  Systemic lupus erythematosus,  Neutrophils,  NETosis,  Reactive oxygen species